Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
CPRX holding history
Catalyst Pharmaceuticals, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,254,355
- Value
- $70.9M
- % of portfolio
- 0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,254,355 | $70.9M | 0.1% | +1,841,689+446.3% | Added | Holders |
| Q1 2026 | 412,666 | $10.2M | <0.1% | −74,469−15.3% | Reduced | Holders |
| Q4 2025 | 487,135 | $11.4M | <0.1% | −334,067−40.7% | Reduced | Holders |
| Q3 2025 | 821,202 | $16.2M | <0.1% | −193,208−19.0% | Reduced | Holders |
| Q2 2025 | 1,014,410 | $22.0M | <0.1% | +254,114+33.4% | Added | Holders |
| Q1 2025 | 760,296 | $18.4M | <0.1% | +101,044+15.3% | Added | Holders |
| Q4 2024 | 659,252 | $13.8M | <0.1% | −7,988−1.2% | Reduced | Holders |
| Q3 2024 | 667,240 | $13.3M | <0.1% | +538,506+418.3% | Added | Holders |
| Q2 2024 | 128,734 | $1.99M | <0.1% | +38,484+42.6% | Added | Holders |
| Q1 2024 | 90,250 | $1.44M | <0.1% | +90,250 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −64,578−100.0% | Sold out | Holders |
| Q3 2023 | 64,578 | $754.9K | <0.1% | +64,578 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −121,873−100.0% | Sold out | Holders |
| Q4 2022 | 121,873 | $2.27M | <0.1% | +121,873 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −122,638−100.0% | Sold out | Holders |
| Q2 2022 | 122,638 | $860.0K | <0.1% | −31,071−20.2% | Reduced | Holders |
| Q1 2022 | 153,709 | $1.27M | <0.1% | −24,611−13.8% | Reduced | Holders |
| Q4 2021 | 178,320 | $1.21M | <0.1% | +93,818+111.0% | Added | Holders |
| Q3 2021 | 84,502 | $448.0K | <0.1% | +40,238+90.9% | Added | Holders |
| Q2 2021 | 44,264 | $255.0K | <0.1% | +44,264 | New | Holders |